1.23
price up icon1.65%   0.02
after-market 시간 외 거래: 1.22 -0.01 -0.81%
loading

Enveric Biosciences Inc 주식(ENVB)의 최신 뉴스

pulisher
Jun 16, 2025

Enveric Biosciences Announces Participation in 2025 BIO International Convention | ENVB Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Enveric Biosciences Announces Participation in 2025 BIO International Convention - Business Wire

Jun 16, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice Of Allowance For New Class Of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class o - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences (ENVB) Gains Patent Approval for Innovative Compounds | ENVB Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders | ENVB Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders - Yahoo Finance

Jun 10, 2025
pulisher
Jun 04, 2025

Enveric Receives U.S. Patent for Sleep, CNS Therapeutics - Insider Monkey

Jun 04, 2025
pulisher
Jun 03, 2025

Enveric’s Patent Win Targets New Frontiers in Sleep Medicine - microdose.buzz

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences (ENVB) Secures Patent for Novel CNS Therapeu - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Receives New US Patent on Molecules for Central Nervous System, Sleep Therapeutics - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences secures patent for sleep disorder molecules By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences (ENVB) Secures Patent for Novel CNS Therapeutic Compounds | ENVB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds | ENVB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds - Yahoo Finance

Jun 03, 2025
pulisher
May 29, 2025

Enveric Biosciences announces results from EB-003 trial - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Enveric’s EB-003 shows statistically significant improvements in model of severe chronic depression - BioWorld MedTech

May 29, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results For Lead Drug Candidate EB-003 - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences reports breakthrough in depression model By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (ENVB) Reports Promising Preclinical Results - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences reports breakthrough in depression model - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (ENVB) Reports Promising Preclinical Results for EB-003 | ENVB Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003 | ENVB Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003 - Business Wire

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (NASDAQ:ENVB) Stock Price Down 0.8% – Here’s Why - Defense World

May 28, 2025
pulisher
May 20, 2025

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences Stakes Its Claim in Neurodegeneration Market - microdose.buzz

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences files provisional patent for new molecules By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences Identifies Neuroplastogen Candidates with Po - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences (ENVB) Explores New Path with Neurodegenerative Drug Patent | ENVB Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences files new provisional patent application - TipRanks

May 20, 2025
pulisher
May 14, 2025

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results - BioSpace

May 14, 2025
pulisher
May 14, 2025

Enveric Biosciences Reports First Quarter 2025 Financial and Cor - GuruFocus

May 14, 2025
pulisher
May 11, 2025

Enveric Biosciences (ENVB) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
Apr 30, 2025

Enveric Biosciences stock plummets after pricing $5M capital raise - MSN

Apr 30, 2025
pulisher
Apr 17, 2025

Enveric Biosciences (NASDAQ:ENVB) Trading Down 1% – Here’s Why - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Enveric Biosciences appoints new accounting firm - Investing.com India

Apr 15, 2025
pulisher
Apr 14, 2025

Enveric Biosciences appoints new accounting firm By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 05, 2025

ENVB Stock Touches 52-Week Low at $1.12 Amid Market Challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

ENVB Stock Touches 52-Week Low at $1.12 Amid Market Challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

Psychedelic: Enveric, Filament Health report earnings results - TipRanks

Apr 03, 2025
pulisher
Apr 01, 2025

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024 - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

Enveric posts $9.5M loss for 2024, but revenue could be on horizon with licensing deals - Green Market Report

Mar 31, 2025
pulisher
Mar 31, 2025

Enveric Lands Massive $184M Biotech Licensing Deals as EB-003 Shows Promise - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Enveric Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Enveric Biosciences, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Enveric Biosciences Inc. (ENVB) reports earnings - qz.com

Mar 28, 2025
pulisher
Mar 21, 2025

Enveric Biosciences Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 18, 2025

Enveric Biosciences Announces 1-for-15 Reverse Stock Split - MSN

Mar 18, 2025
pulisher
Mar 17, 2025

Enveric Biosciences Participating in BIO-Europe Spring® - The Bakersfield Californian

Mar 17, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):